Hartfalen: epidemiologie, risicofactoren en toekomst

RIVM Rapport 260401006
among elderly patients in general practice setting: cross sectional survey.
BMJ 318, 368-72.
Mosley WJ, 2nd, Greenland P, Garside DB, Lloyd-Jones DM (2007). Predictive
utility of pulse pressure and other blood pressure measures for cardiovascular
outcomes. Hypertension 49, 1256-64.
Mosterd A, Hoes AW, De Bruyne MC, Deckers JW, Linker DT, Hofman A, Grobbee
DE (1999). Prevalence of heart failure and left ventricular dysfunction in the
general population; The Rotterdam Study. Eur Heart J 20, 447-55
Mosterd A, Cost B, Hoes AW, De Bruijne MC, Deckers JW, Hofman A, Grobbee
DE (2001). The prognosis of heart failure in the general population: The
Rotterdam Study. Eur Heart J 22, 1318-27.
Mosterd A, Reitsma JB, Grobbee DE (2002). Angiotensin converting enzyme
inhibition and hospitalisation rates for heart failure in the Netherlands, 1980
to 1999: the end of an epidemic? Heart 87, 75-6.
Mosterd A, Hoes AW (2007). Clinical epidemiology of heart failure. Heart 93(9):
1137-46.
Mouly-Bertin C, Bissery A, Milon H, Dzudie A, Rabilloud M, Bricca G, Vincent M,
Lantelme P (2008). N-terminal pro-brain natriuretic peptide--a promising
biomarker for the diagnosis of left ventricular hypertrophy in hypertensive
women. Arch Cardiovasc Dis 101, 307-15.
Movahed MR, Martinez A, Greaves J, Greaves S, Morrell H, Hashemzadeh M
(2008). Left ventricular hypertrophy is associated with obesity, male gender,
and sympoms in health adolescents. Obesity 17: 606-10.
Mozaffarian D, Bryson CL, Lemaitre RN, Burke GL, Siscovick DS (2005). Fish
intake and risk of incident heart failure. J Am Coll Cardiol 45, 2015-21.
Mozaffarian D, Lemaitre RN, King IB, Song X, Spiegelman D, Sacks FM, Rimm
EB, Siscovick DS (2011). Circulating long-chain omega-3 fatty acids and
incidence of congestive heart failure in older adults: the cardiovascular health
study: a cohort study. Ann Intern Med 155, 160-70.
Mudd JO, Kass DA (2008). Tackling heart failure in the twenty-first century.
Nature 451(7181): 919-28.
Mueller T, Gegenhuber A, Poelz W, Haltmayer M (2004). Head-to-head
comparison of the diagnostic utility of BNP and NT-proBNP in symptomatic
and asymptomatic structural heart disease. Clin Chim Acta 341, 41-8.
Murdoch DR, Love MP, Robb SD, Mcdonagh TA, Davie AP, Ford I, Capewell S,
Morrison CE, Mcmurray JJ (1998). Importance of heart failure as a cause of
death. Changing contribution to overall mortality and coronary heart disease
mortality in Scotland 1979-1992. Eur Heart J 19, 1829-35.
Murphy NF, Macintyre K, Stewart S, Hart CL, Hole D, Mcmurray JJ (2006). Longterm
cardiovascular consequences of obesity: 20-year follow-up of more than
15 000 middle-aged men and women (the Renfrew-Paisley study). Eur Heart
J 27, 96-106.
Myerson M, Coady S, Taylor H, Rosamond WD, Goff DC, Jr. (2009). Declining
severity of myocardial infarction from 1987 to 2002: the Atherosclerosis Risk
in Communities (ARIC) Study. Circulation 119, 503-14.
Najafi F, Dobson AJ, Hobbs M, Jamrozik K (2007a). Temporal trends in the
frequency and longer-term outcome of heart failure complicating myocardial
infarction. Eur J Heart Fail 9, 879-85.
Najafi F, Dobson AJ, Jamrozik K (2007b). Recent changes in heart failure
hospitalisations in Australia. Eur J Heart Fail 9, 228-33.
Najafi F, Dobson AJ, Hobbs M, Jamrozik K (2008). Late-onset heart failure after
myocardial infarction: trends in incidence and survival. Eur J Heart Fail 10(8):
765-71.
Pagina 108 van 122